165 results
Page 2 of 9
8-K
EX-10.1
lr2p9j17w82
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.3
btz9m1mryb 7baq08okz
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-4.1
koyau6l y1qoqvldxt
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
vca8fch
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
2dwe8
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
2kn 5b3q3ufp
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
74f2yh2ia4z vmpf
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
i0i4pnc485qkw
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.1
m93wfomd
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
z07r2 9121ywrc3
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
96tiwrcj0j nuc54jd5c
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.2
sad9di
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
hgatv
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.1
cesi9rs17l0c8gb5n
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
lk32i
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
ytqygw2a 4rs6
30 Oct 23
Regulation FD Disclosure
8:05am